Conversion from Continuous Insulin Infusions to Subcutaneous Insulin in Critically III Patients
The DOI matches its Crossref record.
Abstract
Background: Continuous insulin infusions have become a standard of care in many intensive care units (ICUs); however, methods for transitioning patients from continuous infusions to other insulin therapies have not been extensively evaluated. Objective: To determine the most effective method for transitioning ICU patients from continuous insulin infusions to subcutaneous insulin therapy. Methods: A searchable pharmacy database at the University of North Carolina Hospitals was used to retrospectively identify adults admitted to the neurosurgery ICU and prescribed a continuous insulin infusion between May 2007 and February 2008, All patients were transitioned to subcutaneous insulin upon floor transfer. Patients were stratified according to the dose of subcutaneous insulin as a percentage of their prior 24-hour continuous insulin requirement and then analyzed on the rate of achievement of goal blood glucose values (80–150 mg/dL) within the first 48 hours after transition. Results: A total of 769 blood glucose values from 79 patients were recorded during the study. Data analysis demonstrated significantly lower median blood glucose values with the use of subcutaneous insulin doses that were 60–70% of insulin infusion requirements when compared with all other groups. For patients without a history of diabetes mellitus, the use of a subcutaneous dose that was 60–70% of the insulin infusion requirement resulted in a significantly greater percentage of patients within the target range compared with other groups (78%; p < 0.05). For those with a history of diabetes, subcutaneous doses higher than 70% of the insulin infusion requirement yielded the most frequent achievement of target values, although there was substantial variability within this group. No significant difference was noted in the incidence of hypoglycemia (blood glucose <80 mg/dL) between groups, although the frequency of hypoglycemia was almost twice as high in the group with diabetes as in those without it (4.2% vs 2.2%). Conclusions: Methods currently used to transition patients off insulin infusions vary widely. Initial data suggest that utilizing 60–70% of the 24-hour insulin infusion requirement as a subcutaneous dose would result in blood glucose values of 80–150 mg/dL 70% of the time. Further study is necessary to adequately assess the optimal insulin infusion transition protocol for critically ill patients to ensure both safety and efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Jacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
International recommendations for glucose control in adult non diabetic critically ill patients
Ichai, C., Preiser, J.-C., (SFAR), F. T. S. F. D.-R., & Société de Réanimation de langue Française (SRLF) and the Experts group (2010) · Critical Care · doi:10.1186/cc9258 · Cited by 127
Hsia, E., Seggelke, S., Gibbs, J., Hawkins, R. M., Cohlmia, E., Rasouli, N., Wang, C., Kam, I., & Draznin, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1244 · Cited by 112
Transitioning safely from intravenous to subcutaneous insulin
Kreider, K. E., & Lien, L. F. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0595-4 · Cited by 36
Lim, Y., Ohn, J. H., Jeong, J., Ryu, J., Kim, S.-W., Cho, J. H., Park, H.-S., Kim, H. W., Lee, J., Kim, E. S., et al. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1341 · Cited by 14
“Although several different methods of transition from IV insulin have been described [6-9], rebound hyperglycemia remains a major challenge in practice [10,11].”
BackgroundTransition from intravenous to subcutaneous insulin in critically ill adults
Doolin, M. K., Walroth, T. A., Harris, S. A., Whitten, J. A., & Fritschle-Hilliard, A. C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816629985 · Cited by 13
“This finding is consistent with literature which has shown that patients with DM may require higher doses of insulin upon transition.(11) A secondary analysis found no difference in the percentage of BG concentrations within the target range following transition at 0-12 hours (Figure 5) and 12-24 hours (Figure 6), whi…”
BackgroundResultInfluentialZhou, K., Buehler, L. A., Zaw, T., Bena, J., & Lansang, M. C. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2021.10.003 · Cited by 3
Metadata
- Authors
- Weant, K. A., & Ladha, A.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2009-03-31
- Volume
- 43
- Issue
- 4
- Pages
- 629-634
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2142423931
- Cited by
- 31
- References
- 0
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.